Glycerine Zuigelingen Sopreli

Glycerine Zuigelingen Sopreli is a rectally administered product containing glycerol as the sole active ingredient. It is marketed in the European Union and classified as an excipient rather than a therapeutic drug. The preparation is supplied in a liquid or suppository form, though specific strength and dosage form details are not disclosed. It is intended for use as a rectal laxative or stool softener in appropriate clinical contexts.

Glycerine Zuigelingen Sopreli is primarily employed as a rectal agent to facilitate bowel movements in individuals who need stool softening or mild laxation, especially when oral preparations are not appropriate.

- Softens hardened fecal matter by drawing water into the colon, making evacuation easier. - Provides temporary relief of occasional constipation without systemic absorption. - May be used in pediatric, adult, or elderly patients under healthcare professional guidance. - Acts as a lubricant during diagnostic rectal examinations or minor procedures. - Offers an alternative when oral osmotic or stimulant laxatives are contraindicated.

The safety profile of rectally administered glycerol, the active component of Glycerine Zuigelingen Sopreli, reflects its local action in the gastrointestinal tract, with most reported effects being mild, transient, and limited to the site of administration.

Common: - Mild rectal irritation or burning sensation that usually resolves after a short period. - Temporary increase in stool frequency or softer stool consistency. - Slight abdominal cramping, bloating, or gas that diminishes with continued use. - Loose stools or mild diarrhea, especially if higher volumes are administered.

Serious: - Severe rectal bleeding or hemorrhage requiring medical attention. - Persistent or worsening abdominal pain that does not improve after discontinuation. - Signs of electrolyte imbalance such as dizziness, muscle weakness, or irregular heartbeat.

When using Glycerine Zuigelingen Sopreli, certain precautions should be observed to minimize risks and ensure appropriate use, especially in vulnerable populations.

- Confirm that the product is intended for rectal use and follow the label instructions. - Avoid use in patients with known hypersensitivity to glycerol or any excipients. - Do not use in cases of intestinal obstruction, perforation, or severe inflammatory bowel disease. - Limit duration of use to the shortest period necessary to achieve the desired effect. - Monitor for signs of dehydration or electrolyte disturbance, particularly in elderly or pediatric patients. - Seek medical advice before use during pregnancy or lactation, as safety data are limited.

Glycerol administered rectally has limited systemic absorption, yet certain drug interactions and concurrent conditions should be considered.

Avoid: - Concurrent use of strong stimulant laxatives, which may increase the risk of severe diarrhea or electrolyte loss. - Co‑administration with rectal enemas containing irritant substances that could exacerbate mucosal irritation.

Use with caution: - Combination with oral osmotic laxatives (e.g., polyethylene glycol) may lead to additive laxative effect. - Patients taking medications that affect fluid balance, such as diuretics, should be monitored for dehydration. - Observe for increased abdominal discomfort when combined with other rectal preparations. - Caution when combined with medications that cause constipation, such as opioids, as the effect may be reduced.